circumference were both negatively correlated with testosterone levels, with the association being stronger for waist circumference. HbA 1 C level also reveal a negative association with sexual dysfunction and hypogonadotropic hypogonadism among type 2 diabetic men. Metabolic syndrome is also associated with the low serum testosterone levels in the study subjects. Conclusions: This study reveals that serum total testosterone levels are lower in diabetic men with signs/symptoms of hypogonadism .Hypogonadotropic hypogonadism is frequent in diabetic hypogondal population. There is an association between poor glycaemic control and hypogonadism in male diabetic persons. 
Introduction
Type 2 diabetes is the predominant form of diabetes worldwide, accounting for 90% of cases globally. 1, 2 Asian Indians have surprisingly higher prevalence of type 2 diabetes compared to Caucasians. Excessive insulin resistance in Asian Indians compared to Caucasians may be one of the contributing factors. This difference in the degree of insulin resistance may be explained by either an environmental or a genetic factor or by combination of both. [3] [4] [5] [6] [7] [8] [9] [10] .Diabetes mellitus is a medical condition which is often associated with male sexual dysfunction. Erectile dysfunction (ED) is estimated to occur in 28-75% of diabetic males and its prevalence appears to increase with age & duration of diabetes. [11] [12] [13] [14] The etiology of ED in type 2 diabetes is often multifactorial and include poor metabolic control, diabetes-induced micro-and macrovascular alterations, autonomic neuropathy, hypogonadism, or a combination of all these factors. [15] [16] [17] Type 2 diabetes, which is not an autoimmune disorder is also associated with other endocrine diseases, in particular hypogonadism in men. Androgen deficiency has recently come to the forefront of the medical literature after being ignored for decades. Important associations are being developed and confirmed in the literature between androgen deficiency and metabolic disorders. More specifically, there is an important health impact related to metabolic syndrome (MetS), insulin resistance (IR), type 2 diabetes and ultimately vascular disease and erectile dysfunction (ED). Low concentrations of testosterone are linked with IR and implicated in hyperglycaemia, hypertension, dyslipidaemia, and an increased risk of vascular disease. [18] [19] [20] [21] [22] [23] Insulin resistance is an important feature of type 2 diabetes. It is being increasingly recognized that low . testosterone levels in men are associated with reduced insulin sensitivity and type 2 diabetes. 24 Serum testosterone levels are lower in a large number of Japanese patients with type 2 diabetes when compared with healthy men and suggested that testosterone supplementation in hypogonadal men could decrease IR and atherosclerosis. 22 These observations suggest that androgen deficiency plays a central role in the various pathologies encompassing the components of MetS including type 2 diabetes, IR, obesity and ED.
Various guidelines for the diagnosis of hypogonadism are available. Joint guidelines for the diagnosis and treatment of men with late onset hypogonadismtestosterone deficiency associated with aging have been produced by the International Society for the Study of the Aging male (ISSAM) and the European Associatin for Urology (EAU). 25 They recommend that, a total testosterome < 8 nmol /L in the presence of symptoms requires substitution and >12 nmol/L does not. In symptomatic men with a total testosterone between 8 and 12 nmol /L trials of therapy can be considered. Both the American Association of clinical Endocrinology and the Endocrine Society recommend that the diagnosis of hypogonadism should based on low serum testosterone levels and signs / symptoms. 26, 27 Signs and symptoms of low testosterone levels in adults, are decreased energy level, reduced or loss of libido, diminished spontaneous erectile function, depression, poor concentration and memory, hot flushes or sweats, and infertility. 26 The clinical signs of hypogonadism are usually only manifest in the more overt cases and include fine wrinkling of facial skin, eunuchoid body habitus, loss of secondary sexual hair, decreased lean body mass, increased body fat, decrease testicular volume, gynaecomastia and osteoporosis .
Current evidence shows that there is a significant proportion of men with type 2 diabetes who have hypogonadism. Although, androgen status in diabetic men is not routinely considered by the majority of medical practitioners, symptomatic patients should be considered to measure serum testosterone levels. The present study was designed to assess hypogonadism in type 2 diabetic men, referred to Endocrine Department, BIRDEM. The general objective of the study was to identify the clinical hypogonadism, based on signs / symptoms and biochemical measures available, in type 2 diabetic Bangladeshi men. The specific objectives of the study were to find out the type of hypogonadism in type 2 diabetic subjects and to find assosiation between low testosterone level and glycaemic status in type 2 diabetic subjects.
Materials and Methods
The study was conducted in the Dept. 
Study Subjects:
Study subjects were selected purposively about 450 patients was interviewed at outdoor and indoor department of Endocrinology, BIRDEM. After taking brief history, preliminary selection was done on the basis of signs/ symptoms of hypogonadism and exclusion of other systemic illnesses. 350 patients were enlisted their name after primary selection. History taken and clinical examination performed with a pre-structured questionnaire. Next morning following an overnight (10-12 hours) fast blood sample was collected. One hundred and seventy subjects were attended and investigated properly. A diagnosis of hypogonadism was made if anybody had symptoms/ signs of hypogonadism and total testosterone d" 12 nmol/L. In a patient with low testosterone level LH. FSH, Prolactin and SHBG were measured for further assessment.
Anthropometric measurements and other physical examinations:
Standing height and weight was measured using appropriate scales. Body mass index (BMI) of the subjects were calculated using the formula: BMI = Weight (kg)/(Height in meter) 2. Waist circumference was measured to the nearest 0.5 cm with a soft nonelastic measuring tape. The tape was snug, but not so tight as to cause skin indentation or pinching. Horizontal arm span (between the out spread middle fingertips with the patient standing against a flat backboard) was measured to the nearest 0.5 cm .Lower segment was measured from the top of the symphysis pubis vertically to the floor with the subject standing straight. Then the upper segment was determined by subtracting the lower segment from the standing height measurement noted above. Breast staging was done according to Marshal and Tanner stages of breast development. After proper exposure of the subjects, pattern of pubic hair was seen and the stage of pubic hair was determined by marshal and Tanner staging. Testicular volume was estimated with the Prader Orchidometer.The fully stretched dorsal penile length was measured in the flaccid state from the pubopenile skin junction to the tip of the glans .Subjects were requested to fast at least 10 hours and fasting venous blood sample (10 ml) was collected between 8.00-9.00 A.M.
Statistical analysis:
Statistical analysis was performed using SPSS software for Windows Version 11.5.All data were expressed as mean with 95% confidence interval and percentage (%) as appropriate.
Results and Observations
A total of 170 diabetic subjects were studied.
Clinical and biochemical characteristics of study subjects. .8±5.4 in eugonadal subjects respectively. Serum total testosterone (nmol/l) as mean ±SD in hypogonadal subjects was 9.5±1.8, whereas in eugonadal subjects was 18.6±4.1. Serum SHBG (nmol/l), and prolactin (mIU/ml) level were not significantly different between the hypogonadal and eugonadal subjects . Serum LH and FSH (mIU/ml) was significantly (p=0.001, p=0.020) lower in hypogonadal subjects than the eugonadal subjects .
In this study, there was significant difference in testicular volume, HbA 1 C level, serum TG, total testosterone, and LH , FSH level between the hypogoadal and eugonadal subjects. 
Past medical history of study subjects
Past history of hypertension was found 33.9% and 24.5% of hypogonadal and eugonadal subjects respectively. Previous history of coronary artery disease (CAD) was found 2.7% of eugonadal subjects. Both hypertension and CAD were found 1.8% of eugonadal subjects. But in majority of the subjects (66.1% of hypogonadal and 70.9% eugonadal), no significant past illness was found.
Distribution of hypogonadism among the study subjects according to different age groups Maximum subjects were found 40-49 years age group. Fifty or more than 50 age group were 17(28.8%) and 20-29 years age group was 1(1.7%).
Association of low testosterone levels with clinical variables in study subjects (n=170) BMI >25(kg/m 2 ) was found in 32(54.2%) hypogonadal subjects and 47(42.3%) eugonadal subjects. Waist circumference WC e" 90 cm was found in 53(89.8%) hypogonadal subjects and 71(64.0%) eugonadal subjects. Hypertension was found in 28(47.5%) hypogonadal subjects and 44(39.6%) eugonadal subjects. History of smoking was found in 23(39.0%) hypogonadal subjects and 56(50.5%) eugonadal subjects. History of regular exercise was found in 47(79.7%) hypogonadal and 84(75.7%) eugonadal subjects. History of alcohol ingestion was found in 5(8.5%) hypogonadal and 5(4.5%) eugonadal subjects. Sensory neuropathy was found in 8(13.6%) hypogonadal and 23(20.7%) eugonadal subjects. 
Correlation of BMI , waist circumference and with HbA 1 C total testosterone
Total testosterone was correlated inversely with BMI and waist circumference in study subjects. Total testosterone was negatively correlated with HbA 1 C level in study subjects.
Fig. 1: Correlation of BMI and total testosterone in study subjects

Fig. 2: Correlation of waist circumference and total testosterone in study subjects
Discussion
Previous studies 19 showed that about one third of type 2 diabetic men have low serum testosterone levels, but these studies had not correlated this value with symptoms. The present study clearly shows that there is a high prevalence of symptomatic hypogonadism in men with type 2 diabetes.
In the Baltimore longitudinal study on aging 8, 12, 19 and 28% of men aged > 40, 50, 60 and 70 years, respectively, had serum total testosterone levels below the normal range 28 . In the present study, the mean total testosterone levels in diabetic men were also progressively lower in higher age groups. The frequencies of hypogonadal symptoms were similar in all age-groups of low testosterone in the present study and supported the similar results found in a previous study. 29 Gonadotropin Concentrations were not elevated in most of the hypogonadal subjects of type 2 diabetes in present study, and thus the primary defect in these patients would appear to be either in the pituitary gland or hypothalamus. In fact, the LH and FSH levels were significantly lower in the hypogonadal group than the eugonadal group. To rule out the possibility that the cause of hypogonadotropic hypogonadism was a pituitary lesion, MRI of pituitary and perisellar region was done in 15 randomly selected hypogonadal subjects. None of the MRIs showed pituitary or hypothalamic abnormalities. Previously in a study, it was similarly found high prevalence of hypogonadotropic hypogonadism in type 2 diabetes. 19 In this study, testosterone level is inversely correlated with waist circumference and BMI. A Possible explanation for this is the hypogonadal obesity cycle. 30 Essentially, visceral adipocytes have a high activity of the enzyme aromatase which converts testosterone to estrogen. Testosterone inhibits the enzyme lipoprotein lipase ,which takes up free fatty acids into adipocytes. Lower levels of testosterone result in increased triglyceride levels in adipocytes, which promote further adipocyte proliferation and hence higher aromatase activity. In this study, it was also shown that serum total testosterone negatively correlated with HbA 1 C level. This observation may suggest relation of hypogonadism to poor glycaemic control.
Serum testosterone levels have been reported to be lower in men with hypertension. 31 But the present study did not show a significant association between testosterone levels and history of hypertension. Similarly, this study found no significant association between testosterone levels and smoking. The majority of cross-sectional studies have shown that low testosterone levels are associated with a pro-atherogenic lipid profile high total and LDL cholesterol and triglycerides (TG) and low HDL cholesterol 32 . In this study, high TG and low HDL were found more in hypogonadal subjects than the eugonadal subjects, but the total cholesterol and LDL cholesterol did not vary between the two groups.
In this study, higher prevalence of metabolic syndrome (according to IDF criteria) was found among the hypogonadal subjects. Different components of metabolic syndrome were also significantly higher among the hypogonadal subjects than the eugonadal subjects. These observations suggest that androgen deficiency plays a central role in the various pathologies encompassing the components of metS including central obesity, insulin resistance, hyperglycaemia, dyslipidaemia and hypertension.
Conclusion:
This study reveals that serum total testosterone levels are lower in diabetic men with signs/symptoms of hypogonadism .Hypogonadotropic hypogonadism is frequent in diabetic hypogondal population. There is an association between poor glycaemic control and hypogonadism in male diabetic persons.
